From lab to clinic: the evolving translational landscape of nucleic acid therapeutics
Nucleic Acid Insights is delighted to present the latest updates in the nucleic acids field through this new Industry Update, which highlights recent preclinical and translational R&D advances across oligonucleotides, mRNA, DNA therapeutics, as well as associated formulation and delivery technologies.
Authors
- Jimmy J. Weterings
- Christian H. Ottensmeier (ORCID: https://orcid.org/0000-0003-3619-1657)
- Piotr S. Kowalski (ORCID: https://orcid.org/0000-0001-8607-0189)
- John W. Lewis
Institutions
- University of Liverpool (GB)
- University College Cork (IE)
- CASI Pharmaceuticals (United States) (US)
- Io Therapeutics (United States) (US)
Publication Details
- Journal
- Nucleic Acid Insights
- Published
- 2025-09-25
- DOI
- https://doi.org/10.18609/nuc.2025.026
- Primary Topic
- RNA Interference and Gene Delivery
- Type
- article
- Field-Weighted Citation Impact
- 0.00